Hashimoto’s Thyroiditis: A Complete Guide to Diagnosis, Treatment, and Long-Term Management

Hashimoto’s thyroiditis is an autoimmune disease in which the immune system attacks the thyroid gland, and it is the most common cause of hypothyroidism in the United States and other iodine-sufficient countries, according to Pearce, Farwell and Braverman in the New England Journal of Medicine (2003). It is diagnosed with a blood panel of TSH, free T4 and thyroid peroxidase (TPO) antibodies, which are present in roughly 90% of patients, treated with daily levothyroxine when hormone levels fall, and monitored for life with labs every 6 to 12 months once stable.

What Is Hashimoto’s Thyroiditis?

Hashimoto’s thyroiditis is an autoimmune condition where your immune system mistakenly identifies thyroid tissue as foreign and mounts a sustained attack against it. Over time, this chronic immune assault destroys thyroid cells, gradually reducing the gland’s ability to produce thyroid hormones. The result is hypothyroidism: insufficient thyroid hormone to meet the body’s needs.

Named after Japanese physician Dr. Hakaru Hashimoto, who first described it in 1912, Hashimoto’s is by far the most common cause of hypothyroidism in the United States and other iodine-sufficient countries [1]. It affects women roughly 5 to 10 times more often than men and typically develops between the ages of 30 and 50, though it can appear at any age, including in children and teenagers.

Clinicians use several names for the same disease: Hashimoto’s disease, Hashimoto’s thyroiditis (often shortened to HT), chronic lymphocytic thyroiditis, and autoimmune thyroiditis. Hashimoto’s and Graves’ disease together make up autoimmune thyroid disease (AITD). Graves’ disease pushes the thyroid to overproduce hormone, while Hashimoto’s slowly shuts production down.

Hashimoto’s is primarily an immune system problem, not a thyroid problem. The thyroid is the target, not the cause. This distinction matters because conventional treatment typically focuses only on replacing the missing thyroid hormone while ignoring the autoimmune process that is still actively destroying the gland. A more complete approach addresses both.

How Common Is Hashimoto’s?

Thyroid autoimmunity is common in the United States. In the NHANES III national survey, Hollowell and colleagues (2002) found TPO antibodies in 11.3% and thyroglobulin antibodies in 10.4% of the US population, and hypothyroidism in 4.6% (0.3% clinical and 4.3% subclinical) [17]. Not everyone with antibodies develops hypothyroidism, but antibody positive people carry a clearly higher lifetime risk.

Hashimoto’s also clusters with other autoimmune conditions. People with Hashimoto’s are more likely to have or develop celiac disease, type 1 diabetes, vitiligo, pernicious anemia, and rheumatoid arthritis. The broader pattern is covered in our overview of autoimmune disease symptoms.

The Pathology: What Is Actually Happening in the Thyroid

In Hashimoto’s, two main types of autoantibodies are involved:

Thyroid peroxidase (TPO) antibodies: TPO is an enzyme essential for thyroid hormone production. When the immune system produces antibodies against TPO, it directly impairs the thyroid’s ability to make hormones. TPO antibodies are present in roughly 90% of Hashimoto’s patients and are the most commonly tested marker [2].

Thyroglobulin (Tg) antibodies: Thyroglobulin is a protein used by the thyroid as a scaffold for hormone synthesis. Antibodies against thyroglobulin are found in about 50 to 70% of Hashimoto’s cases. Some patients have elevated Tg antibodies with normal TPO antibodies, which is why testing both is important. If only TPO is checked, a percentage of Hashimoto’s cases will be missed.

Microscopically, the thyroid gland in Hashimoto’s shows heavy lymphocytic infiltration: the tissue is packed with immune cells (primarily T-lymphocytes and B-lymphocytes) that are actively attacking thyroid follicular cells. Over months and years, this process progressively replaces functional thyroid tissue with fibrous scar tissue and immune cell aggregates. On ultrasound, this appears as a heterogeneous, hypoechoic (dark) gland, often with a characteristic “moth-eaten” or “pseudonodular” appearance.

How Does Hashimoto’s Progress Over Time?

Hashimoto’s usually moves through three stages over years. First, antibodies are present while TSH and free T4 are still normal (euthyroid autoimmunity). Next, TSH rises while free T4 stays in range (subclinical, or mild, hypothyroidism). Finally, free T4 falls below range and overt hypothyroidism needs treatment.

The pace varies widely between people. In the 20-year follow-up of the Whickham Survey in northern England, Vanderpump and colleagues (1995) found that women with both a raised TSH and positive thyroid antibodies had an odds ratio of 38 for developing hypothyroidism, compared with 8 for either finding alone [18]. Antibodies plus a rising TSH is the combination that most strongly predicts the need for thyroid hormone.

Hashimoto’s also comes in two physical forms. In the goitrous form the gland enlarges into a firm, painless goiter. In the atrophic form the gland shrinks as tissue is replaced by fibrosis. Both forms are treated the same way.

Symptoms of Hashimoto’s

Thyroid hormones regulate metabolism in virtually every cell in your body. When production falls, the effects are widespread. Many patients describe feeling like their entire system is running in slow motion.

Common Symptoms

• Persistent fatigue that does not improve with sleep
• Unexplained weight gain or difficulty losing weight despite appropriate diet and exercise
• Cold intolerance: feeling cold when others are comfortable, cold hands and feet
• Brain fog: difficulty concentrating, poor memory, slowed thinking
• Hair loss, including thinning of the outer third of the eyebrows
• Constipation
• Dry skin and brittle nails
• Depression, low mood, or emotional flatness
• Joint pain and muscle stiffness, particularly in the morning
• Menstrual irregularities: heavy periods, irregular cycles, or infertility
• Hoarse voice or feeling of throat fullness
• Elevated cholesterol that does not respond to dietary changes
• Puffy face and swelling around the eyes, especially in the morning

Many of these symptoms overlap with perimenopause, iron deficiency anemia, depression, chronic fatigue syndrome and fibromyalgia, which is one reason Hashimoto’s is often found late. A longer symptom-by-symptom breakdown is in our post on Hashimoto’s symptoms, and the overlap with cognitive complaints is covered in common causes of brain fog.

The Problem with “Subclinical” Hashimoto’s

Many patients with Hashimoto’s are told their labs are “normal” or that they have “subclinical” hypothyroidism that does not need treatment. This typically means their TSH is elevated but still within the standard reference range (usually up to 4.5 to 5.0 mIU/L), or their TSH is slightly elevated with a normal free T4.

The problem is that many of these patients are profoundly symptomatic. The standard lab reference ranges are based on population statistics, not on what is optimal for an individual. A TSH of 4.0 may be “normal” by lab standards but far too high for a particular person to feel well. The optimal ranges discussed under “Optimal vs. Normal Reference Ranges” below explain why. If your labs keep coming back normal while you feel unwell, our post on normal blood work when you still feel sick walks through the next questions to ask.

Hashimoto’s Flares

Hashimoto’s does not always progress smoothly. Many patients experience “flares” where the autoimmune attack intensifies, causing a burst of thyroid cell destruction. When thyroid cells are destroyed, they release stored thyroid hormone into the bloodstream all at once. This can temporarily cause hyperthyroid symptoms: anxiety, rapid heartbeat, tremors, insomnia, diarrhea, and feeling hot.

These flares (sometimes called “Hashitoxicosis”) are confusing because the symptoms swing from hypo to hyper and back. They are often triggered by stress, illness, hormonal changes, or dietary triggers. If you have Hashimoto’s and suddenly feel wired, anxious, and have a racing heart, a flare is a likely explanation. Our guide to Hashimoto’s flares covers how to recognize one and what to track.

Diagnosis: Getting the Right Tests

One of the biggest failures in Hashimoto’s care is inadequate testing. Many doctors test only TSH. Some add free T4. Very few routinely order the full panel needed to accurately diagnose and monitor Hashimoto’s.

A diagnosis of Hashimoto’s rests on two findings: positive TPO or thyroglobulin antibodies, and either abnormal thyroid hormone levels or the typical ultrasound pattern. Hypothyroidism alone does not prove Hashimoto’s, and positive antibodies alone do not mean you need medication yet.

The Essential Thyroid Panel

• TSH (Thyroid Stimulating Hormone): Produced by the pituitary gland, TSH signals the thyroid to make more hormone. When thyroid output drops, TSH rises. It is useful as a screening test, but it is a pituitary hormone, not a thyroid hormone, and it does not tell you the whole story.
• Free T4 (Thyroxine): The primary hormone produced by the thyroid. “Free” means the unbound, biologically active form.
• Free T3 (Triiodothyronine): T3 is the active thyroid hormone that actually drives metabolism in cells. T4 must be converted to T3 to be useful. Many patients convert poorly, and checking free T3 is the only way to identify this.
• TPO Antibodies: The primary marker for Hashimoto’s autoimmunity.
• Thyroglobulin Antibodies: The secondary marker. Testing both antibody types catches cases that would be missed by TPO alone.
• Reverse T3 (optional but informative): An inactive form of T3. Elevated reverse T3 can indicate conversion problems, chronic stress, or inflammation.

What Each Thyroid Test Tells You

Thyroid Ultrasound

A thyroid ultrasound is a valuable and underused diagnostic tool. It can reveal the characteristic changes of Hashimoto’s (heterogeneous echotexture, hypoechogenicity, increased vascularity) even before antibodies become elevated in the blood. It can also identify thyroid nodules, which occur more frequently in Hashimoto’s patients than in the general population [3]. Any suspicious nodules should be evaluated further with fine-needle aspiration.

Optimal vs. “Normal” Reference Ranges

This is one of the most important concepts in Hashimoto’s management. Standard lab reference ranges are wide. A TSH of 0.5 to 4.5 mIU/L, for example, is considered “normal” by most labs. But research and clinical experience suggest that optimal thyroid function for most people corresponds to narrower ranges:

• TSH: 0.5 to 2.0 mIU/L (many patients feel best between 1.0 and 1.5)
• Free T4: Upper half of the reference range
• Free T3: Upper half of the reference range (often 3.0 to 4.0 pg/mL or higher)
• TPO Antibodies: As low as possible; ideally under 35 IU/mL (the lower the better)
• Thyroglobulin Antibodies: As low as possible

The National Academy of Clinical Biochemistry has noted that 95% of individuals without thyroid disease have a TSH below 2.5 mIU/L, suggesting that the upper limit of current reference ranges is too high [4]. This is why a patient with a TSH of 3.5 can feel terrible despite being told everything is “normal.”

These narrower targets are a clinical judgment, not a consensus standard. The NHANES III data from Hollowell and colleagues (2002) put the mean TSH of the disease-free US population at 1.50 mIU/L [17], which supports aiming lower for symptomatic patients, but mainstream endocrinology guidelines still treat the full lab range as normal. Older adults often run a higher TSH without harm, so targets should be set individually.

Hashimoto’s vs. Hypothyroidism vs. Graves’ Disease

Hashimoto’s is a cause, and hypothyroidism is the result. Most hypothyroidism in the US is due to Hashimoto’s, but hypothyroidism can also follow thyroid surgery, radioactive iodine, certain medications or iodine deficiency. Graves’ disease is the other autoimmune thyroid disease, and it drives the gland the opposite way.

The full comparison is in our post on Hashimoto’s vs. hypothyroidism, and the condition overview lives in our Hashimoto’s thyroiditis explainer.

Who Diagnoses Hashimoto’s?

Most people are diagnosed by a primary care physician, an internist or an OB-GYN who orders a thyroid panel for fatigue, weight change or fertility problems. An endocrinologist is the specialist for complex cases, pregnancy, nodules or persistent symptoms on treatment. Functional medicine physicians, naturopathic doctors (in states that license them) and integrative nurse practitioners often order the full antibody panel and look at triggers alongside hormone levels.

Conventional Treatment

Hashimoto’s hypothyroidism is treated by replacing the hormone the gland can no longer make. The American Thyroid Association’s 2014 guidelines, written by Jonklaas and colleagues, name levothyroxine as the standard of care [2]. Treatment is usually prescribed by a primary care physician or an endocrinologist and is covered by most insurance plans.

Levothyroxine (T4 Only)

Levothyroxine (brand names include Synthroid, Tirosint, and Levoxyl) is synthetic T4 and is the standard first-line treatment for Hashimoto’s hypothyroidism. It is well-studied, stable, and effective for many patients. The typical starting dose ranges from 25 to 75 mcg depending on the severity of hypothyroidism, patient weight, age, and cardiac health, with gradual adjustments based on lab results every 6 to 8 weeks.

For many patients, T4 monotherapy works well. Their body converts the T4 to active T3 efficiently, and they feel good. A meaningful subset of patients, estimated at 10 to 15% or more, continue to experience symptoms despite having “normal” TSH on levothyroxine [5]. These patients may have issues with T4-to-T3 conversion, and they deserve further investigation rather than being told “your labs are fine.”

How levothyroxine is taken matters as much as the dose. It is absorbed best on an empty stomach with water, 30 to 60 minutes before breakfast or at bedtime well after the last meal. Calcium, iron, magnesium supplements, coffee and soy can all reduce absorption, so many clinicians ask patients to separate them by several hours and to keep the timing consistent day to day.

Adding Liothyronine (T3)

Liothyronine (Cytomel) is synthetic T3. Adding a small dose of T3 to T4 therapy (combination therapy) can make a significant difference for patients who convert T4 to T3 poorly. A typical approach is to reduce the T4 dose slightly and add 5 to 15 mcg of T3 daily, often split into two doses because T3 has a shorter half-life than T4.

Combination T4/T3 therapy remains controversial in mainstream endocrinology, with some professional guidelines advising against it due to mixed results in clinical trials. Patient preference studies consistently show that a significant number of patients feel better on combination therapy [6]. The DIO2 gene polymorphism, which affects T4-to-T3 conversion, may explain why some patients benefit from added T3 while others do not [7].

Natural Desiccated Thyroid (NDT)

Natural desiccated thyroid (brands include Armour Thyroid, NP Thyroid, and Nature-Throid) is derived from porcine thyroid glands and contains both T4 and T3, along with small amounts of T2 and T1 and calcitonin. NDT was the standard treatment for hypothyroidism for over a century before synthetic levothyroxine was introduced in the 1960s.

NDT has a passionate following among patients, and some clinical studies suggest equivalent or superior outcomes compared to levothyroxine in certain patient populations [8]. Critics note that the T4:T3 ratio in NDT (approximately 4:1) is higher in T3 relative to the human thyroid’s natural production ratio (approximately 14:1). In practice, many clinicians who use NDT address this by combining it with supplemental T4 or by dosing carefully with lab monitoring.

NDT is regulated differently from levothyroxine. The FDA has not approved desiccated thyroid products through a new drug application, they are marketed as older unapproved drugs, and the ATA 2014 guidelines do not recommend them as first-line therapy [2]. Many patients still use them under a prescriber’s supervision.

Comparing Thyroid Hormone Options

There is no single “right” medication for everyone with Hashimoto’s. The most useful approach is to work with a provider who is open to different options and willing to adjust based on how you actually feel, not just what the lab numbers show.

Do You Need Treatment If Your Labs Are Only Mildly Abnormal?

Whether to treat subclinical hypothyroidism is a judgment call. Many clinicians treat when TSH is above 10 mIU/L, when a woman is pregnant or trying to conceive, or when antibodies are positive and symptoms are clear. Below that threshold, some prescribe a trial of levothyroxine and reassess after 3 to 6 months, while others recheck labs and wait. Rising antibodies and a climbing TSH strengthen the case for starting earlier.

Triggers and Root Causes

Autoimmune diseases do not appear out of nowhere. The prevailing model holds that autoimmunity requires three ingredients: genetic susceptibility, an environmental trigger, and intestinal permeability (often called “leaky gut”) [9]. Identifying and addressing your specific triggers is one of the most powerful things you can do to slow disease progression and reduce antibody levels.

The intestinal permeability piece of this model comes largely from the work of Alessio Fasano and colleagues on zonulin and the gut barrier. It is a well-supported hypothesis rather than a settled cause for Hashimoto’s specifically, and testing for “leaky gut” in clinics is not standardized. Our overview of leaky gut explains what is known and what is still debated.

Gluten

The connection between gluten and Hashimoto’s is one of the most studied and most debated topics in thyroid autoimmunity. The molecular structure of gliadin (a protein in gluten) resembles thyroid tissue closely enough that the immune system may attack both through a process called molecular mimicry. Multiple studies have found that a gluten-free diet reduces TPO antibodies in patients with Hashimoto’s, and patients with celiac disease have significantly higher rates of thyroid autoimmunity [10].

Not every Hashimoto’s patient needs to go gluten-free. But for those who are sensitive, the impact can be dramatic. A 3 to 6 month strict elimination trial is the most practical way to assess individual response. If symptoms and antibody levels improve, the answer is clear. Ask for a celiac antibody test before cutting gluten, because the test becomes unreliable once gluten is gone; our guide to celiac disease vs. gluten sensitivity explains the difference.

Stress

Chronic psychological stress is a well-documented trigger for autoimmune flares. Stress hormones (particularly cortisol) shift the immune system in ways that can worsen autoimmune activity. Many Hashimoto’s patients can identify a period of extreme or prolonged stress that preceded their diagnosis or a major symptom flare. Addressing stress is not optional; it is a core part of managing Hashimoto’s.

Infections

Several infections have been linked to triggering Hashimoto’s, including Epstein-Barr virus (EBV), Helicobacter pylori, Yersinia enterocolitica, and hepatitis C [11]. EBV has received particular attention, as a high percentage of Hashimoto’s patients show evidence of past or reactivated EBV infection. The mechanism likely involves molecular mimicry and chronic immune activation.

Pregnancy and Postpartum

Pregnancy is a common trigger for Hashimoto’s. During pregnancy, the immune system suppresses itself to tolerate the fetus. After delivery, the immune system rebounds, sometimes aggressively. This “immune rebound” can trigger postpartum thyroiditis, which may be an initial presentation of Hashimoto’s or a flare in someone with pre-existing disease. Up to 10% of women develop postpartum thyroid dysfunction [12].

Iodine Excess

While iodine is essential for thyroid hormone production, too much iodine can worsen Hashimoto’s. Excess iodine increases hydrogen peroxide production in the thyroid, which can accelerate TPO-mediated damage in someone with existing autoimmunity. This is why high-dose iodine supplementation (such as Lugol’s solution or high-dose kelp) is generally not recommended for Hashimoto’s patients without careful monitoring [13].

Other Environmental Triggers

• Toxin exposure: Heavy metals (mercury, lead), pesticides, and industrial chemicals can trigger or worsen autoimmunity
• Gut dysbiosis and intestinal permeability: The gut houses roughly 70% of the immune system. Disruptions in gut health are almost always involved in autoimmune disease
• Nutrient deficiencies: Selenium, vitamin D, zinc, and iron deficiencies all affect thyroid and immune function
• Other medications: Lithium, amiodarone, and interferon-alpha are known to trigger thyroid autoimmunity

Concern about heavy metals and mold exposure is common among people with autoimmune disease, but the evidence linking them directly to Hashimoto’s is limited. If exposure is a real possibility, start with validated blood testing through your physician; our pages on heavy metal testing and toxic mold exposure cover what those tests can and cannot show.

Integrative Approaches

These interventions do not replace thyroid hormone when it is needed, but they can slow the autoimmune process, reduce antibody levels, improve symptoms, and in some cases allow dose reductions in thyroid medication. Most are supported by small trials rather than large, long-term studies, and most are paid out of pocket when delivered through integrative or functional medicine clinics.

Selenium

Selenium is the single most studied nutrient for Hashimoto’s. Multiple randomized controlled trials have shown that selenium supplementation (typically 200 mcg daily of selenomethionine) significantly reduces TPO antibody levels [14]. Selenium is required for the enzymes that convert T4 to T3 (deiodinases) and also plays a key role in antioxidant defense within the thyroid gland itself. Brazil nuts are the richest dietary source: 1 to 2 nuts per day can provide roughly 100 to 200 mcg of selenium, though content varies by soil.

The evidence is more mixed than antibody numbers alone suggest. A Cochrane systematic review by van Zuuren and colleagues (2013) concluded that the trials were too small and too short to show whether selenium improves quality of life or slows progression to hypothyroidism [19]. Selenium also has a narrow margin between enough and too much, so long-term high doses should be agreed with a clinician.

Vitamin D

Vitamin D deficiency is extremely common in Hashimoto’s patients, and low vitamin D is associated with higher antibody levels and worse disease progression. Supplementing to achieve a blood level of 40 to 60 ng/mL (100 to 150 nmol/L) is a reasonable target for most patients. Doses of 2,000 to 5,000 IU daily are commonly needed, though individual requirements vary based on baseline levels, body weight, and sun exposure [15]. Our post on vitamin D optimization covers testing and dosing in more depth.

Zinc

Zinc is necessary for thyroid hormone synthesis and for proper immune function. Deficiency is common in hypothyroid patients, and supplementation (25 to 30 mg daily) has been shown to improve T3 levels and support immune regulation. Zinc competes with copper for absorption, so long-term zinc supplementation should include a small amount of copper (1 to 2 mg) to prevent deficiency.

Gluten-Free Diet

As discussed in the triggers section, removing gluten can reduce antibody levels and improve symptoms in susceptible patients. This is not about following a fad. For patients with confirmed gluten sensitivity or celiac disease, it is a targeted therapeutic intervention based on the molecular mimicry mechanism between gliadin and thyroid tissue. People with confirmed celiac disease can read about how celiac disease is treated alongside thyroid care.

Gut Healing

Since intestinal permeability is considered one of the three pillars of autoimmune disease development, restoring gut barrier function is a central strategy. This may involve removing gut-damaging foods (processed foods, excess sugar, alcohol, and individual trigger foods), treating any infections or dysbiosis (including SIBO, which is common in hypothyroid patients), and supporting the intestinal lining with nutrients like L-glutamine, zinc carnosine, and short-chain fatty acids from fiber or butyrate supplementation.

Slow gut motility from low thyroid hormone is one reason small intestinal bacterial overgrowth shows up so often alongside Hashimoto’s. A breath test can confirm it, and the options are laid out in our page on SIBO treatment approaches.

Stress Management

This is not an afterthought. Chronic stress directly worsens autoimmune activity and impairs thyroid function. Evidence-supported stress management strategies include regular physical activity (appropriate to energy levels), meditation or mindfulness practice, adequate sleep (7 to 9 hours), time in nature, social connection, and professional support for trauma or chronic anxiety. Vagus nerve stimulation through cold exposure, gargling, or humming may also help modulate the inflammatory response, though the evidence for these home techniques is early; see the vagus nerve and autoimmunity.

Low-Dose Naltrexone (LDN)

LDN (typically 1.5 to 4.5 mg at bedtime) is an increasingly popular option in integrative thyroid care. At these low doses, naltrexone temporarily blocks opioid receptors, causing a rebound increase in endorphin production and modulating immune function. Clinical observations and some published data suggest that LDN can reduce thyroid antibodies and improve symptoms in Hashimoto’s patients [16]. LDN requires a prescription and is typically obtained from compounding pharmacies.

Naltrexone is FDA approved at 50 mg for alcohol and opioid use disorder, so using it at low doses for Hashimoto’s is off label. No large randomized trial has tested LDN in Hashimoto’s, and LDN is not recommended in ATA guidelines. Our posts on LDN for Hashimoto’s and what to avoid on LDN cover dosing questions and interactions, including why it should not be combined with opioid pain medication.

How Strong Is the Evidence for Each Approach?

Diet for Hashimoto’s: What the Research Shows

No single diet treats Hashimoto’s, but diet can lower inflammation and help some patients feel better. The patterns with the most attention are a gluten-free diet, the autoimmune protocol (AIP) and a broadly anti-inflammatory, Mediterranean style of eating built on vegetables, fish, olive oil and legumes.

The autoimmune protocol removes grains, legumes, dairy, eggs, nightshades, nuts and seeds, then reintroduces them one at a time. In a 2019 pilot by Abbott and colleagues, 16 women with Hashimoto’s who completed a 10-week AIP coaching program reported better quality of life and fewer symptoms, and their high-sensitivity C-reactive protein fell by 29%, while thyroid antibodies did not change significantly [20]. That is an encouraging signal from a small, uncontrolled study, not a settled result.

Practical food points for Hashimoto’s:

• Keep iodine moderate: iodized salt and normal food sources are fine; high-dose kelp and iodine drops are not.
• Do not fear cooked cruciferous vegetables: normal servings of broccoli, kale and cabbage are not a problem when iodine intake is adequate.
• Time soy and fiber supplements: they can reduce levothyroxine absorption, so keep them away from your dose.
• Eat enough protein and iron: low ferritin is common in Hashimoto’s, especially with heavy periods, and worsens fatigue and hair loss.

Meal plans and food lists are in our Hashimoto’s diet guide and our walk-through of the autoimmune protocol diet.

Hashimoto’s and Pregnancy

Thyroid function is critically important during pregnancy. Untreated or undertreated hypothyroidism increases the risk of miscarriage, preterm birth, preeclampsia, and impaired neurological development in the baby [12].

Key considerations for Hashimoto’s patients who are pregnant or planning pregnancy:

• Optimize thyroid levels before conception. A preconception TSH of 0.5 to 2.5 mIU/L is generally recommended.
• Thyroid hormone requirements increase during pregnancy, often by 25 to 50%. Most women need a dose increase as early as 4 to 6 weeks of gestation. Do not wait for symptoms to appear; proactive dose adjustment based on labs every 4 weeks during the first trimester is the standard of care.
• TPO-positive women are at higher risk for postpartum thyroiditis and should be monitored closely in the 6 to 12 months after delivery.
• TSH targets during pregnancy are trimester-specific: generally under 2.5 mIU/L in the first trimester and under 3.0 mIU/L in the second and third trimesters, though newer guidelines suggest population-based reference ranges may be more appropriate.

The newer guidance is the American Thyroid Association’s 2017 pregnancy guideline by Alexander and colleagues, which replaced the fixed 2.5 and 3.0 cutoffs with population and trimester-specific ranges and suggests an upper limit of about 4.0 mIU/L when local ranges are not available [21]. It also advises women already on levothyroxine to raise their dose by roughly 20 to 30% as soon as pregnancy is confirmed, then follow their obstetrician or endocrinologist’s lab schedule.

Monitoring and Long-Term Management

Hashimoto’s is a lifelong condition. It does not “go away,” though the autoimmune activity can be reduced to minimal levels with the right approach. Long-term management involves regular lab monitoring, medication adjustments as needed, and ongoing attention to the triggers and lifestyle factors that influence disease activity.

How Often to Test

• When adjusting medication: Recheck TSH, free T4, and free T3 every 6 to 8 weeks until stable.
• Once stable: Full panel (TSH, free T4, free T3, TPO antibodies) every 6 to 12 months.
• During pregnancy: Monthly monitoring in the first trimester, then every 4 to 6 weeks.
• After a flare or significant stress: Test within 4 to 6 weeks to assess impact.

Tracking Antibodies Over Time

Antibody levels are not just diagnostic markers. They are a window into how active the autoimmune process is. Falling antibodies indicate that whatever you are doing (dietary changes, stress management, supplements, removing triggers) is working. Rising antibodies are a signal to investigate what has changed: new stress, a dietary trigger, a new infection, or worsening gut health.

Antibody numbers also vary between laboratories and assays, so compare results from the same lab whenever possible. Antibody levels do not set the levothyroxine dose; TSH and free hormone levels, together with symptoms, do.

Thyroid Cancer Screening

Hashimoto’s patients have a modestly increased risk of papillary thyroid cancer and thyroid lymphoma. Regular thyroid ultrasound (every 1 to 2 years for those with nodules, otherwise as clinically indicated) is a reasonable monitoring strategy. Any rapidly growing nodule or nodule with suspicious ultrasound features should be evaluated with fine-needle aspiration biopsy [3].

Working with Your Healthcare Team

Managing Hashimoto’s well often requires a team approach. An endocrinologist or experienced primary care provider handles medication. A functional or integrative medicine practitioner can help investigate root causes and triggers. A knowledgeable dietitian can guide dietary changes. And a therapist or stress management coach can address the psychological and emotional burden of living with a chronic autoimmune condition.

If your current provider is dismissive of your symptoms, refuses to test beyond TSH, or insists that your labs are “fine” when you feel awful, it is appropriate to seek a second opinion. You know your body. Lab values are one piece of the puzzle, not the entire picture.

Finding a Clinician for Hashimoto’s Care

Hashimoto’s care usually combines a prescriber who manages thyroid hormone with clinicians who work on diet, nutrients and triggers. Endocrinologists and primary care physicians are typically in network with insurance. Functional and integrative clinics, which more often run full antibody panels, nutrient testing and elimination diets, are frequently cash pay, so ask what is billed to insurance before booking.

Many clinics that offer hormone care also manage thyroid medication. You can browse clinics offering hormone replacement therapy and check each profile for thyroid testing, levothyroxine or T3 prescribing and lab follow-up, and read the hormone replacement therapy treatment guide to understand what those clinics typically do. For thyroid patients near menopause, our page on menopause symptoms and care covers the overlap.

A few points about how the directory works. Clinics are not ranked by payment, so the order you see is not a paid placement. Featured slots are clearly labeled and limited in number. A Verified badge means the clinic completed our credential checks, not that it spent money with us. Regenerated.com is free for patients, and being listed is not an endorsement. The guide to Featured, Verified and organic listings explains each label.

Questions worth asking any clinic before a first visit:

1. Will you test TPO and thyroglobulin antibodies and free T3, not only TSH?
2. Which thyroid medications do you prescribe, and how do you decide between them?
3. How often will labs be repeated, and are they billed to insurance?
4. Will you coordinate with my endocrinologist or primary care physician?
5. What evidence do you rely on for supplements, diet changes or LDN?

Related Reading

• SIBO: A Complete Guide: SIBO is common in hypothyroid patients due to slowed gut motility.
• Vitamin D and Autoimmune Disease: Why optimizing vitamin D is critical for managing Hashimoto’s and other autoimmune conditions.
• Gut Health Fundamentals: The connection between intestinal permeability and autoimmune thyroid disease.
• Thyroid Symptoms: How underactive and overactive thyroid symptoms differ.
• LDN for Autoimmune Conditions: How low-dose naltrexone is used across autoimmune diseases, and where the evidence stands.

Frequently Asked Questions

Can Hashimoto’s be reversed or go into remission?

Hashimoto’s cannot be reversed; it is a lifelong autoimmune condition. What can change is how active it is. With thyroid hormone replacement where needed, attention to triggers such as gluten in sensitive people, and nutrients such as selenium and vitamin D, many patients see lower antibody levels and fewer symptoms. Thyroid tissue that has already been replaced by scar tissue does not regrow, so long-term monitoring stays necessary even when you feel well.

Which blood tests are used to diagnose and monitor Hashimoto’s?

Hashimoto’s is diagnosed and monitored with TSH, free T4, free T3, TPO antibodies and thyroglobulin antibodies, not TSH alone. TPO antibodies are present in roughly 90% of patients and thyroglobulin antibodies in about 50 to 70%, so testing both catches more cases. A thyroid ultrasound adds detail on gland texture and nodules. When medication is being adjusted, labs are rechecked every 6 to 8 weeks until stable, then every 6 to 12 months.

Does going gluten-free actually help with Hashimoto’s?

A gluten-free diet helps some people with Hashimoto’s, especially those with celiac disease or gluten sensitivity. Several studies, including work by Sategna-Guidetti and colleagues (2001), link gluten withdrawal to improved thyroid markers, and people with celiac disease have higher rates of thyroid autoimmunity. Results without celiac disease are mixed. A strict 3 to 6 month elimination trial, with antibody tests before and after and a celiac test before you start, is the practical way to judge your own response.

Can selenium lower thyroid antibodies?

Selenium can lower TPO antibody levels, according to several randomized controlled trials and a 2014 meta-analysis using about 200 mcg of selenomethionine daily. One to two Brazil nuts provide roughly 100 to 200 mcg, though content varies. A 2013 Cochrane review found the trials too small to show effects on quality of life or progression to hypothyroidism. No specific percentage drop or timeline is established, and high doses over long periods should be discussed with a clinician.

What is low-dose naltrexone (LDN) and does the evidence support it?

Low-dose naltrexone is naltrexone taken at 1.5 to 4.5 mg at bedtime, far below the 50 mg dose the FDA approved for addiction. It is used off label in Hashimoto’s to modulate immune activity. The evidence is limited to clinical observations and small published reports; no large randomized trial has tested it in Hashimoto’s. LDN needs a prescription, is usually made by compounding pharmacies, and should not be combined with opioid pain medication.

Why do some people still feel unwell on levothyroxine?

An estimated 10 to 15% or more of people on levothyroxine keep having symptoms despite a normal TSH. Common reasons include poor conversion of T4 to active T3, sometimes linked to the DIO2 gene, absorption problems from taking the pill with food, coffee, calcium or iron, and ongoing autoimmune activity. Some prescribers lower the T4 dose slightly and add 5 to 15 mcg of liothyronine (T3) daily. Checking free T3, ferritin and vitamin D is a reasonable next step.

Sources

1. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348(26):2646-2655. doi:10.1056/NEJMcp021194
2. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults. Thyroid. 2012;22(12):1200-1235. doi:10.1089/thy.2012.0205
3. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133. doi:10.1089/thy.2015.0020
4. Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13(1):3-126. doi:10.1089/thy.2002.12.1063
5. Peterson SJ, Cappola AR, Castro MR, et al. An online survey of hypothyroid patients demonstrates prominent dissatisfaction. Thyroid. 2018;28(6):707-721. doi:10.1089/thy.2017.0681
6. Escobar-Morreale HF, Botella-Carretero JI, Gomez-Bueno M, et al. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med. 2005;142(6):412-424. doi:10.7326/0003-4819-142-6-200503150-00007
7. Panicker V, Saravanan P, Vaidya B, et al. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab. 2009;94(5):1623-1629. doi:10.1210/jc.2008-1301
8. Hoang TD, Olsen CH, Mai VQ, Clyde PW, Shakir MK. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab. 2013;98(5):1982-1990. doi:10.1210/jc.2012-4107
9. Fasano A. Leaky gut and autoimmune diseases. Clin Rev Allergy Immunol. 2012;42(1):71-78. doi:10.1007/s12016-011-8291-x
10. Sategna-Guidetti C, Volta U, Ciacci C, et al. Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal. Am J Gastroenterol. 2001;96(3):751-757. doi:10.1111/j.1572-0241.2001.03617.x
11. Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity. Endocr Rev. 1993;14(1):107-120. doi:10.1210/edrv-14-1-107
12. Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2011;21(10):1081-1125. doi:10.1089/thy.2011.0087
13. Leung AM, Braverman LE. Consequences of excess iodine. Nat Rev Endocrinol. 2014;10(3):136-142. doi:10.1038/nrendo.2013.251
14. Fan Y, Xu S, Zhang H, et al. Selenium supplementation for autoimmune thyroiditis: a systematic review and meta-analysis. Int J Endocrinol. 2014;2014:904573. doi:10.1155/2014/904573
15. Mazokopakis EE, Papadomanolaki MG, Tsekouras KC, et al. Is vitamin D related to pathogenesis and treatment of Hashimoto’s thyroiditis? Hell J Nucl Med. 2015;18(3):222-227. doi:10.1007/s12020-015-0533-2
16. Younger J, Parkitny L, McLain D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol. 2014;33(4):451-459. doi:10.1007/s10067-014-2517-2
17. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499. doi:10.1210/jcem.87.2.8182
18. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43(1):55-68. doi:10.1111/j.1365-2265.1995.tb01894.x
19. van Zuuren EJ, Albusta AY, Fedorowicz Z, Carter B, Pijl H. Selenium supplementation for Hashimoto’s thyroiditis. Cochrane Database Syst Rev. 2013;(6):CD010223. doi:10.1002/14651858.CD010223.pub2
20. Abbott RD, Sadowski A, Alt AG. Efficacy of the autoimmune protocol diet as part of a multi-disciplinary, supported lifestyle intervention for Hashimoto’s thyroiditis. 2019;11(4):e4556. PubMed 31275780
21. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315-389. doi:10.1089/thy.2016.0457